Top 22 Lysosomal Therapeutics investors
The most complete profiles first. Showing 22 of 22.
Ben ScruggsVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more
Verified email available
Douglas ReedVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedAndroidLife SciencePortfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more
Verified email available
Jeff TerrellVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedAndroidLife SciencePortfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more
Verified email available
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
John CrumplerVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedAndroidLife SciencePortfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 47 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Meredith FisherVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Roger KittermanVerified
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Jason P. HaflerVerified
Corporate Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Laia CrespoVerified
Venture Capital, Corporate Venture Capital, Investor · France
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Verified email available
Michael DialVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more
Verified email available
Robert MorffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedAndroidLife SciencePortfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more
Verified email available
Carl Berke
Venture Capital, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Kseniya Simpson, PhD
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedAndroidLife SciencePortfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more
Contact details available
Daniel Mansuri
Corporate Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Contact details available
Ed Torres
Corporate Venture Capital · United States
Health CareAlternative MedicineWomen FoundedInformation Technology (IT)Portfolio: Avid Radiopharmaceuticals, GlobeImmune, Sutro Biopharma, Cerulean Pharma and 30 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Julius Knowles
Venture Capital, Design Operator, Strategy Operator · United States
Health CareHospitalsWellnessWomen FoundedPortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Ruoxi Hu
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Lysosomal Therapeutics investors are on Angel Roster?
Angel Roster lists 22 Lysosomal Therapeutics investors. 14 of them (64%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Private Equity Firms (6) and Corporate Venture Capital Firms (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Lysosomal Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (8) and Series B (2).
Where are Lysosomal Therapeutics investors based?
Most are based in the United States (21) and France (1).
Which companies have Lysosomal Therapeutics investors backed?
The most-backed portfolio companies among them are Kymera Therapeutics (17), Vigil Neuroscience (13), Rodin Therapeutics (13), Raze Therapeutics (11) and Triplet Therapeutics (11).
How do I contact Lysosomal Therapeutics investors?
Create a free Angel Roster account to search and filter all 22, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.